DEFSEC Technologies Inc. announced a private placement of 1,951,219 common shares and pre-funded warrants at CAD$2.84 per share, accompanied by common warrants to purchase an equal number of shares exercisable at CDN$3.30 for 60 months. The offering is expected to generate approximately CDN$5.54 million (US$4.0 million) in gross proceeds, with H.C. Wainwright & Co. serving as the exclusive placement agent. Net proceeds will fund business development, intellectual property protection, and working capital. The transaction is anticipated to close on or about August 18, 2026, pending TSX Venture Exchange approval. DEFSEC Technologies Inc. develops and commercializes next-generation tactical systems for military and security forces.

DEFSEC Technologies Inc. reported third quarter fiscal 2026 results with revenue of $2,722.2 thousand CAD, a 92% increase from the prior year period. Gross margin expanded to 33.1%, up from 28.2%, while operating expenses rose to $3,463.1 thousand CAD, resulting in an Adjusted EBITDA loss of $(1,942.7) thousand CAD. The company completed testing of its BLISS™ system with the U.S. Army and received an invitation for additional evaluations. Additionally, DEFSEC commercially released DEFSEC Lightning™ 2.0 and ARWEN® 40mm ammunition. The company operates in the defense technology sector, developing tactical systems, software platforms, and less-lethal products for military and security forces.